Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Furberg

Showing results (201-210 of 205) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 205 results.
Controlled Clinical Trials|February 13, 2001
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)S L Pressel, B R Davis, J T Wright, et al.
Circulation|January 4, 2001
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart AssociationL B Goldstein, R Adams, K Becker, et al.
Stroke|January 4, 2001
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart AssociationL B Goldstein, R Adams, K Becker, et al.
American Journal of Hypertension|April 1, 1996
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research GroupB R Davis, J A Cutler, D J Gordon, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
Pageof 21

Showing results (201-210 of 205) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 205 results.
Controlled Clinical Trials|February 13, 2001
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)S L Pressel, B R Davis, J T Wright, et al.
Circulation|January 4, 2001
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart AssociationL B Goldstein, R Adams, K Becker, et al.
Stroke|January 4, 2001
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart AssociationL B Goldstein, R Adams, K Becker, et al.
American Journal of Hypertension|April 1, 1996
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research GroupB R Davis, J A Cutler, D J Gordon, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
Pageof 21